{"id":"sodium-tartrate","rwe":[],"tags":[{"label":"sodium tartrate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"A06AD21","category":"atc"},{"label":"Active","category":"status"},{"label":"Osmotic laxative","category":"indication"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["sodium tartrate","disodium L-tartrate","disodium tartrate","sodium tartrate dihydrate","anhydrous sodium tartrate"],"offLabel":[],"synonyms":["sodium tartrate","disodium L-tartrate","disodium tartrate","sodium tartrate dihydrate","anhydrous sodium tartrate"],"timeline":[],"approvals":[],"ecosystem":[{"indication":"Osmotic laxative","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","drugClass":"sodium tartrate","explanation":"Imagine your intestines as a sponge that needs water to work properly. Sodium tartrate helps to draw water into the sponge, making it easier to pass stool. This process helps to relieve constipation and make bowel movements more regular.","oneSentence":"Sodium tartrate works by drawing water into the intestines through osmosis, softening and loosening stool.","technicalDetail":"Sodium tartrate acts as an osmotic laxative by increasing the osmotic pressure in the intestinal lumen, thereby drawing water into the intestines through the process of osmosis, which helps to soften and loosen stool."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4780","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=sodium%20tartrate","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=sodium tartrate","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:39:48.325602","biosimilars":[],"competitors":[{"drugName":"magnesium carbonate","drugSlug":"magnesium-carbonate","fdaApproval":"1990-10-02","relationship":"same-class"},{"drugName":"magnesium oxide","drugSlug":"magnesium-oxide","fdaApproval":"1982-06-22","relationship":"same-class"},{"drugName":"magnesium sulfate","drugSlug":"magnesium-sulfate","fdaApproval":"1981-10-06","genericCount":12,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"lactulose","drugSlug":"lactulose","fdaApproval":"1976-03-25","genericCount":24,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"lactitol","drugSlug":"lactitol","fdaApproval":"2020-02-12","patentExpiry":"May 12, 2037","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"sodium sulfate","drugSlug":"sodium-sulfate","fdaApproval":"1986-04-30","relationship":"same-class"},{"drugName":"macrogol","drugSlug":"macrogol","fdaApproval":"1984-07-13","relationship":"same-class"},{"drugName":"mannitol","drugSlug":"mannitol","fdaApproval":"1964-06-08","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"sodium phosphate","drugSlug":"sodium-phosphate","fdaApproval":"1983-05-10","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"sorbitol","drugSlug":"sorbitol","fdaApproval":"1971-08-20","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"magnesium citrate","drugSlug":"magnesium-citrate","fdaApproval":"","relationship":"same-class"}],"genericName":"sodium tartrate","indications":{"approved":[{"name":"Osmotic laxative","source":"DrugCentral","snomedId":373571004,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"magnesium-carbonate","brandName":"magnesium carbonate","genericName":"magnesium carbonate","approvalYear":"1990","relationship":"same-class"},{"drugId":"magnesium-oxide","brandName":"magnesium oxide","genericName":"magnesium oxide","approvalYear":"1982","relationship":"same-class"},{"drugId":"magnesium-sulfate","brandName":"magnesium sulfate","genericName":"magnesium sulfate","approvalYear":"1981","relationship":"same-class"},{"drugId":"lactulose","brandName":"lactulose","genericName":"lactulose","approvalYear":"1976","relationship":"same-class"},{"drugId":"lactitol","brandName":"lactitol","genericName":"lactitol","approvalYear":"2020","relationship":"same-class"},{"drugId":"sodium-sulfate","brandName":"sodium sulfate","genericName":"sodium sulfate","approvalYear":"1986","relationship":"same-class"},{"drugId":"macrogol","brandName":"macrogol","genericName":"macrogol","approvalYear":"1984","relationship":"same-class"},{"drugId":"mannitol","brandName":"mannitol","genericName":"mannitol","approvalYear":"1964","relationship":"same-class"},{"drugId":"sodium-phosphate","brandName":"sodium phosphate","genericName":"sodium phosphate","approvalYear":"1983","relationship":"same-class"},{"drugId":"sorbitol","brandName":"sorbitol","genericName":"sorbitol","approvalYear":"1971","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07394101","phase":"NA","title":"Pharmacokinetic Characterization of Tartaric Acid in Humans","status":"NOT_YET_RECRUITING","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2026-04","conditions":["Healthy Adult Participants","Non-smoking, Healthy Adults","Normal Weight Adults"],"enrollment":30,"completionDate":"2026-05"},{"nctId":"NCT05891119","phase":"EARLY_PHASE1","title":"Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis","status":"COMPLETED","sponsor":"Amgen","startDate":"2023-06-03","conditions":["Atopic Dermatitis"],"enrollment":21,"completionDate":"2025-02-12"},{"nctId":"NCT03414008","phase":"PHASE1","title":"This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are Tolerated","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2018-02-05","conditions":["Healthy"],"enrollment":54,"completionDate":"2019-11-18"},{"nctId":"NCT06864234","phase":"PHASE4","title":"Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA","status":"RECRUITING","sponsor":"VZW Cardiovascular Research Center Aalst","startDate":"2025-07-03","conditions":["Coronary Arterial Disease (CAD)","Angina (Stable)","Microvascular Circulation"],"enrollment":46,"completionDate":"2025-12-31"},{"nctId":"NCT06803654","phase":"PHASE3","title":"A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2025-05-22","conditions":["Ocular Redness"],"enrollment":578,"completionDate":"2025-06-29"},{"nctId":"NCT03212677","phase":"NA","title":"Safe and Effective Delivery of Supplemental Iron to Healthy Volunteers","status":"COMPLETED","sponsor":"Tufts University","startDate":"2017-05-17","conditions":["Iron"],"enrollment":226,"completionDate":"2022-07-30"},{"nctId":"NCT03556592","phase":"PHASE1","title":"Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2018-08-13","conditions":["Atopic Dermatitis"],"enrollment":40,"completionDate":"2020-06-20"},{"nctId":"NCT05847517","phase":"PHASE3","title":"Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)","status":"RECRUITING","sponsor":"Consorcio Centro de Investigación Biomédica en Red (CIBER)","startDate":"2024-08-13","conditions":["Acute Respiratory Distress Syndrome (ARDS)"],"enrollment":350,"completionDate":"2027-12"},{"nctId":"NCT04562116","phase":"PHASE2","title":"A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic Dermatitis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2021-12-08","conditions":["Atopic Dermatitis"],"enrollment":17,"completionDate":"2023-06-07"},{"nctId":"NCT02853136","phase":"PHASE1","title":"Influence of Fluvoxamine on the Pharmacokinetics of BI 409306","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2016-08-25","conditions":["Healthy"],"enrollment":18,"completionDate":"2016-10-25"},{"nctId":"NCT04226586","phase":"NA","title":"Nutritional Stimulation of Growth in Children With Short Stature","status":"COMPLETED","sponsor":"Arkansas Children's Hospital Research Institute","startDate":"2020-09-09","conditions":["Nutritional Stunting","Growth Failure"],"enrollment":24,"completionDate":"2022-12-31"},{"nctId":"NCT06524596","phase":"NA","title":"Study on Gynecological Laparoscopy Under Total Intravenous Anesthesia","status":"COMPLETED","sponsor":"Wuhan Children's Hospital","startDate":"2022-01-01","conditions":["Butorphanol"],"enrollment":59,"completionDate":"2023-05-01"},{"nctId":"NCT01343706","phase":"PHASE1","title":"Safety Tolerability and Pharmacokinetic of BI 409306","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2011-04-01","conditions":["Healthy"],"enrollment":80,"completionDate":"2011-08-05"},{"nctId":"NCT03864926","phase":"PHASE4","title":"Envarsus in Delayed Graft Function (E-DGF)","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2019-03-18","conditions":["Delayed Graft Function"],"enrollment":100,"completionDate":"2022-07-22"},{"nctId":"NCT05073055","phase":"NA","title":"Spinal Anesthesia Versus Erector Spina Plane Block","status":"COMPLETED","sponsor":"Nigde Omer Halisdemir University","startDate":"2021-01-01","conditions":["Inguinal Hernia Repair","Postoperative Pain","Peripheral Nerve Blocks"],"enrollment":35,"completionDate":"2022-12-25"},{"nctId":"NCT04375696","phase":"PHASE4","title":"Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects","status":"COMPLETED","sponsor":"Certmedica International GmbH","startDate":"2020-04-24","conditions":["Weight Loss"],"enrollment":150,"completionDate":"2021-12-20"},{"nctId":"NCT03418727","phase":"PHASE2","title":"Dry Eye Disease Study With Brimonidine","status":"COMPLETED","sponsor":"Ocugen","startDate":"2017-09-06","conditions":["Dry Eye"],"enrollment":84,"completionDate":"2018-03-29"},{"nctId":"NCT04716985","phase":"NA","title":"Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care","status":"UNKNOWN","sponsor":"AGIR à Dom","startDate":"2021-01-22","conditions":["SARS-CoV-2","Covid19","AMBULATORY CARE"],"enrollment":700,"completionDate":"2023-05-22"},{"nctId":"NCT04909255","phase":"PHASE4","title":"Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder","status":"UNKNOWN","sponsor":"China Medical University Hospital","startDate":"2021-03-23","conditions":["Sjogren's Syndrome","Overactive Bladder Syndrome"],"enrollment":50,"completionDate":"2022-08-15"},{"nctId":"NCT02596828","phase":"PHASE2","title":"Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma","status":"COMPLETED","sponsor":"University of Regensburg","startDate":"2016-04","conditions":["Pineoblastoma"],"enrollment":4,"completionDate":"2021-04"},{"nctId":"NCT01467986","phase":"PHASE2","title":"Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma","status":"COMPLETED","sponsor":"University of Regensburg","startDate":"2013-08","conditions":["Neuroblastoma Recurrent"],"enrollment":130,"completionDate":"2020-09-30"},{"nctId":"NCT01959243","phase":"PHASE3","title":"Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2014-02-22","conditions":["Hyperemia"],"enrollment":507,"completionDate":"2014-06-23"},{"nctId":"NCT01959230","phase":"PHASE3","title":"Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2013-11-07","conditions":["Hyperemia"],"enrollment":60,"completionDate":"2013-12-20"},{"nctId":"NCT03195387","phase":"PHASE1","title":"Chemoprotective Activity of MMV390048 in PfSPZ Challenge Model","status":"WITHDRAWN","sponsor":"Medicines for Malaria Venture","startDate":"2018-01","conditions":["Malaria,Falciparum"],"enrollment":0,"completionDate":"2018-12"},{"nctId":"NCT00383643","phase":"PHASE2","title":"Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.","status":"COMPLETED","sponsor":"Stanford University","startDate":"2006-05","conditions":["Sleep Initiation and Maintenance Disorders"],"enrollment":48,"completionDate":"2009-12"},{"nctId":"NCT02924454","phase":"PHASE4","title":"Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.","status":"COMPLETED","sponsor":"Mikkel Bring Christensen","startDate":"2016-09","conditions":["Drug Overdose","Overdose of Beta-adrenergic Blocking Drug","Blood Pressure"],"enrollment":10,"completionDate":"2017-03-10"},{"nctId":"NCT02635594","phase":"NA","title":"Effects of Carnipure® Tartrate on Postprandial Endothelial Function and Recovery","status":"COMPLETED","sponsor":"Lonza Ltd.","startDate":"2015-12","conditions":["Healthy Volunteers","Recovery","Endothelial Function"],"enrollment":36,"completionDate":"2016-06"},{"nctId":"NCT01050114","phase":"PHASE3","title":"OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER","status":"UNKNOWN","sponsor":"Christopher Patrick Smith","startDate":"2013-08","conditions":["Overactive Bladder"],"enrollment":36,"completionDate":"2018-07"},{"nctId":"NCT00003584","phase":"PHASE2","title":"Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"1998-07","conditions":["Kidney Cancer"],"enrollment":35,"completionDate":"2000-12"},{"nctId":"NCT02211989","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 14332 CL Powder in Healthy Male Subjects","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2006-02","conditions":["Healthy"],"enrollment":53,"completionDate":""},{"nctId":"NCT02180503","phase":"PHASE1","title":"Relative Bioavailability of 1 mg and 10 mg BI 1356 BS as Powder in the Bottle (PIB) to 1 mg and 10 mg BI 1356 BS as Tablets as Single Oral Administration in Healthy Male Volunteers Including the Influence of Food on the Bioavailability of 10 mg BI 1356 BS","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2005-08","conditions":["Healthy"],"enrollment":24,"completionDate":""},{"nctId":"NCT02170896","phase":"PHASE1","title":"Bioavailability of BIBR 963 ZW After 50 mg of BIBR 1048 MS With and Without of Pantoprazole in Healthy Subjects","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2001-10","conditions":["Healthy"],"enrollment":16,"completionDate":""},{"nctId":"NCT02170636","phase":"PHASE1","title":"Bioavailability of BIBR 953 ZW After Oral Administration of BIBR 1048 MS in Healthy Subjects","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2002-01","conditions":["Healthy"],"enrollment":15,"completionDate":""},{"nctId":"NCT01887405","phase":"PHASE4","title":"Comparative Evaluation of Handling Characteristics of Two Adrenaline Autoinjectors,EpiPen in Comparison With Jext","status":"COMPLETED","sponsor":"ALK Nordic A/S, Danmark Filial","startDate":"2012-01","conditions":["Handling of Auto-injectors"],"enrollment":91,"completionDate":"2012-09"},{"nctId":"NCT00857688","phase":"PHASE3","title":"Efficacy of the Combination Bismuth + Neomycin + Procaine in the Treatment of Recurrent Aphthous Ulceration","status":"COMPLETED","sponsor":"Azidus Brasil","startDate":"2011-05","conditions":["Aphtous Ulcers"],"enrollment":100,"completionDate":"2011-11"},{"nctId":"NCT00846287","phase":"NA","title":"Assessment of Arformoterol for Chronic Obstructive Pulmonary Disease (COPD) Using Hyperpolarized 3He MRI","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2008-11","conditions":["Chronic Obstructive Pulmonary Disease"],"enrollment":16,"completionDate":"2011-04"},{"nctId":"NCT00464867","phase":"NA","title":"Effect of Probiotic on Immunogenicity of Oral Cholera Vaccine","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2006-01","conditions":["Cholera"],"enrollment":128,"completionDate":"2008-12"},{"nctId":"NCT01330823","phase":"PHASE3","title":"L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN)","status":"SUSPENDED","sponsor":"University Medicine Greifswald","startDate":"2006-06","conditions":["Pancreatic Carcinoma"],"enrollment":72,"completionDate":"2010-07"},{"nctId":"NCT00519246","phase":"PHASE4","title":"Comparison of Pain Therapeutic Effects After Benign Mastectomy","status":"COMPLETED","sponsor":"Nanjing Medical University","startDate":"2007-02","conditions":["Pain, Postoperative","Mastectomy"],"enrollment":2000,"completionDate":"2007-12"},{"nctId":"NCT00510666","phase":"PHASE4","title":"Comparison of Butorphanol and Tramadol Associated Patient-Controlled Analgesia (PCA) After Hysterectomy","status":"COMPLETED","sponsor":"Nanjing Medical University","startDate":"2007-01","conditions":["Postoperative Pain","Hysterectomy"],"enrollment":841,"completionDate":"2007-05"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"MMSL":"NOCODE","NDDF":"003778","UNII":"QTO9JB4MDD","CHEBI":"CHEBI:63017","RXNORM":"1721438","UMLSCUI":"C0142931","ChEMBL_ID":"CHEMBL2107781","KEGG_DRUG":"D07108","DRUGBANK_ID":"DB13707","PUBCHEM_CID":"162637","SNOMEDCT_US":"24434007","SECONDARY_CAS_RN":"6106-24-7","MESH_SUPPLEMENTAL_RECORD_UI":"C029768"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":175,"therapeuticAreas":["Gastroenterology"],"atcClassification":{"source":"DrugCentral","atcCode":"A06AD21","allCodes":["A06AD21"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"sodium tartrate","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Sodium tartrate is a small molecule used as a food additive, specifically as an emulsifier and binding agent in products such as jellies, margarine, and sausage casings. It is known by the E number E335.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}